Literature DB >> 7544115

Control of coronary blood flow by autacoids.

E Bassenge1.   

Abstract

Coronary flow and thus myocardial perfusion is regulated by myogenic, metabolic, humoral and neuro-hormonal factors which closely interact with local autacoids released from the endothelial lining of the coronary bed. In a number of disease states an impaired synthesis and release of autacoids decisively limit the overall capacity of coronary regulation and adaptation of myocardial perfusion to increased metabolic demands. The important factors for these control mechanisms are analyzed and reviewed in this article.

Mesh:

Substances:

Year:  1995        PMID: 7544115     DOI: 10.1007/bf00789443

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  85 in total

1.  EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries.

Authors:  U Pohl; K Herlan; A Huang; E Bassenge
Journal:  Am J Physiol       Date:  1991-12

2.  An electrophysiological study of microvascular permeability and its modulation by chemical mediators.

Authors:  S P Olesen
Journal:  Acta Physiol Scand Suppl       Date:  1989

3.  Characteristics of canine coronary resistance arteries: importance of endothelium.

Authors:  P R Myers; P F Banitt; R Guerra; D G Harrison
Journal:  Am J Physiol       Date:  1989-08

4.  Myogenic activity in isolated subepicardial and subendocardial coronary arterioles.

Authors:  L Kuo; M J Davis; W M Chilian
Journal:  Am J Physiol       Date:  1988-12

Review 5.  Do we need endothelin antagonists?

Authors:  T F Lüscher
Journal:  Cardiovasc Res       Date:  1993-12       Impact factor: 10.787

6.  Ischemia and reperfusion increase 125I-labeled endothelin-1 binding in rat cardiac membranes.

Authors:  J Liu; R Chen; D J Casley; W G Nayler
Journal:  Am J Physiol       Date:  1990-03

7.  The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina.

Authors:  J Simon; R Gibbs; P A Crean; L Mockus; C Wright; G C Sutton; K M Fox
Journal:  Br Heart J       Date:  1989-08

8.  Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation.

Authors:  G A FitzGerald; B Smith; A K Pedersen; A R Brash
Journal:  N Engl J Med       Date:  1984-04-26       Impact factor: 91.245

9.  Reduced nitric oxide formation causes coronary vasoconstriction and impaired dilator responses to endogenous agonists and hypoxia in dogs.

Authors:  C Huckstorf; J Zanzinger; B Fink; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

10.  Selective thromboxane A2 receptor blockade in experimental exercise-induced myocardial ischaemia in dogs.

Authors:  E Thaulow; B D Guth; R Schulz; J Ross
Journal:  Acta Physiol Scand       Date:  1989-07
View more
  2 in total

1.  A pharmacological analysis of the possible role of vasoactive mediators in compensatory coronary blood flow.

Authors:  James R Parratt; Agnes Végh
Journal:  Exp Clin Cardiol       Date:  2008

2.  Protective skeletal muscle arteriolar vasomotion during critical perfusion conditions of osteomyocutaneous flaps is not mediated by nitric oxide and endothelins.

Authors:  Martin Rücker; Oliver Strobel; Brigitte Vollmar; Wolfgang J Spitzer; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2003-08-29       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.